According to Relmada Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ78.3 M. In 2023 the company made an earning of -โฌ89.15 M an increase over its 2022 earnings that were of -โฌ0.15 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.